Menu

TRACON Pharmaceuticals, Inc. TCON

Full chart Compare
Set alert

Price alert · TCON

All alert types
0.03 0.00 (+0.00%)

At closeJul 16, 2025, 4:00 PM EDT

0.0322 Day range 0.04
0.60 52-week range 17.55
YTD
0.00%
1 year
-94.82%

Revenue & Expenses

Other Income → Expenses: $3.31MExpenses → Selling, General & Admin: $6.67MExpenses → Research & Development: $12.28MOther Operating Income → Expenses: $14.00KGross Profit → Expenses: $12.03MRevenue → Gross Profit: $12.03MRevenue → Cost of Revenue: $14.00KNet Loss → Expenses: $3.59MOther Income$3.31MOther Operating Income$14.00KGross Profit$12.03MNet Loss$3.59MCost of Revenue$14.00KExpenses$18.94MSelling, General & Admin$6.67MResearch & Development$12.28MRevenue$12.04M

Latest period ending Dec 31, 2023 · select a line to chart its full history

TCON annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
12.04M0346.00K00
12.04M0346.00K00
-9.27M-27.89M-28.35M-16.22M-22.30M
-3.59M-29.14M-28.67M-16.77M-22.67M
-2.20-27.80-33.20-37.40-149.40
TCON annual balance sheet
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
8.64M17.50M24.07M32.13M16.41M
10.11M19.47M26.56M37.44M18.12M
10.91M26.62M14.84M12.37M15.42M
-809.00K-7.15M11.71M25.07M2.70M
TCON annual cash flow
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
3.68M-26.24M-22.57M-17.04M-23.65M
-12.54M19.68M10.56M36.76M906.00K
-8.86M-6.57M-8.06M15.72M-8.72M